Celgene Corporation (CELG)

Add to Watchlists Create an Alert
123.44 -0.06  -0.05%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Celgene Corporation Cash from Investing Quarterly:

-251.50M for March 31, 2013
View Full Chart

Celgene Corporation Cash from Investing Quarterly Chart

    Celgene Corporation Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -251.50M
    Dec. 31, 2012 -775.44M
    Sept. 30, 2012 -428.18M
    June 30, 2012 -343.57M
    March 31, 2012 -6.40M
    Dec. 31, 2011 65.69M
    Sept. 30, 2011 142.52M
    June 30, 2011 -106.14M
    March 31, 2011 275.62M
    Dec. 31, 2010 -2.904B
    Sept. 30, 2010 1.573B
    June 30, 2010 -412.63M
    March 31, 2010 -363.55M
    Dec. 31, 2009 -325.51M
    Sept. 30, 2009 1.749M
    June 30, 2009 -220.86M
    March 31, 2009 -311.46M
    Dec. 31, 2008 -222.74M
    Sept. 30, 2008 -59.61M
    June 30, 2008 153.45M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    CELG Cash from Investing Quarterly Benchmarks

    Companies
    Amgen 1.809B
    Athersys -0.04M
    Gilead Sciences

    CELG Cash from Investing Quarterly Rankings

    Overall 47th percentile
    4173 of 8005
    Sector 21st percentile
    538 of 686 in Healthcare
    Industry 19th percentile
    200 of 248 in Biotechnology

    CELG Cash from Investing Quarterly Range, Past 5 Years

    Minimum -2.904B Dec 2010
    Maximum 1.573B Sep 2010
    Average -225.98M